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Adult ventricular myocytesβ1-Adrenergic receptors (β1ARs) and E-type prostaglandin receptors (EPRs) both produce compartmental-
ized cAMP responses in cardiac myocytes. The role of cholesterol-dependent lipid rafts in producing these
compartmentalized responses was investigated in adult rat ventricular myocytes. β1ARs were found in lipid
raft and non-lipid raft containing membrane fractions, while EPRs were only found in non-lipid raft fractions.
Furthermore, β1AR activation enhanced the L-type Ca2+ current, intracellular Ca2+ transient, and myocyte
shortening, while EPR activation had no effect, consistent with the idea that these functional responses are
regulated by cAMP produced by receptors found in lipid raft domains. Using methyl-β-cyclodextrin to disrupt
lipid rafts by depleting membrane cholesterol did not eliminate compartmentalized behavior, but it did
selectively alter speciﬁc receptor-mediated responses. Cholesterol depletion enhanced the sensitivity of
functional responses produced by β1ARs without having any effect on EPR activation. Changes in cAMP
activity were also measured in intact cells using two different FRET-based biosensors: a type II PKA-based
probe to monitor cAMP in subcellular compartments that include microdomains associated with caveolar
lipid rafts and a freely diffusible Epac2-based probe to monitor total cytosolic cAMP. β1AR and EPR activation
elicited responses detected by both FRET probes. However, cholesterol depletion only affected β1AR responses
detected by the PKA probe. These results indicate that lipid rafts alone are not sufﬁcient to explain the
difference between β1AR and EPR responses. They also suggest that β1AR regulation of myocyte contraction
involves the local production of cAMP by a subpopulation of receptors associated with caveolar lipid rafts.AR, beta adrenergic receptor;
-3; PKA, protein kinase A; CGP,
P; EPR, E-type prostaglandin
; IBMX, 3-isobutyl-1- methyl-
soproterenol bitartrate; MβCD,
ostaglandin E1.
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The diffusible second messenger cAMP plays a central role in
regulating many different aspects of cardiac function. This includes
the changes in electrical and mechanical properties of the heart
produced by β1-adrenergic receptor (β1AR) activation in response to
sympathetic stimulation [1,2]. However, a number of different G-
protein-coupled receptors are linked to the production of cAMP in
cardiac myocytes, yet they do not all produce the same functional
responses. The E-type prostaglandin receptors (EPRs) are a classic
example. These receptors stimulate cAMP production in ventricular
myocytes, but they do not elicit changes in electrical or mechanicalactivity [3–6]. This can be explained by the idea that activation of any
given type of receptor does not necessarily produce a uniform
increase in cAMP throughout the entire cell and that cAMP signaling
can be compartmentalized [7].
Despite unequivocal evidence that compartmentation of cAMP
signaling occurs, what is responsible for this behavior is not well
understood. Differences in phosphodiesterase activity have been
shown to be essential for explaining the disparity in cAMP levels that
can exist between different subcellular compartments within the cell
[8,9]. However, phosphodiesterase activity alone cannot explain why
different membrane receptors produce different patterns of cAMP
production. Perhaps the simplest explanation for this observation
assumes that different cytoplasmic compartments are associated with
distinct plasma membrane domains containing unique receptor
populations.
The formation of cholesterol-dependent lipid rafts is hypothesized
to be an important means of organizing the plasma membrane into
discrete signaling domains [10,11]. This includes caveolae, which
represent a subset of lipid rafts that are deﬁned by the presence of the
protein caveolin [12]. It is believed that some proteins can be
concentrated in these cholesterol-rich regions of the plasma
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This includes certain types of G-protein-coupled receptors [14].
Consistent with this hypothesis, disrupting lipid rafts and caveolae
by depleting the membrane of cholesterol has been shown to alter
signaling associated speciﬁcally with receptors believed to exist in
those domains [15–18].
In adult cardiac myocytes, β1ARs are found in caveolar and non-
caveolar fractions of the plasma membrane [19]. On the contrary,
studies using other cell types suggest that at least some EPR subtypes
are excluded from caveolar membrane fractions [20,21]. Furthermore,
we previously demonstrated that β1ARs stimulate cAMP production
in a localized subcellular compartment that includes caveolae, as well
as a bulk cytoplasmic compartment that is believed to exclude
caveolae [22]. Yet, cAMP produced by EPRs could only be detected in
the bulk cytoplasmic compartment [4]. These observations suggest
that inclusion or exclusion of receptors from caveolar lipid raft
domains may be important for determining the subcellular compart-
ment in which they stimulate cAMP production. In the present study,
we tested this hypothesis by examining the effect that cholesterol
depletion has on cAMP-dependent responses as well as cAMP
production associated with β1AR and EPR stimulation in adult
ventricular myocytes.
Materials and methods
Cell isolation and culture
Ventricular myocytes were isolated from the hearts of maleWistar
rats (250–300 g) using a modiﬁcation of the procedure previously
described [23]. The protocol usedwas in accordancewith the Guide for
the Care and Use of Laboratory Animals as adopted by National
Institutes of Health and approved by the Institutional Animal Care and
Use Committee at the University of Nevada, Reno. Myocytes used for
ﬂuorescence resonance energy transfer (FRET) imaging experiments
were resuspended and plated in minimum essential medium (MEM)
containing insulin–transferrin–selenium (1×), bovine serum albumin
(1 mg/ml), 2,3-butanedione monoxime (10 mM), and penicillin–
streptomycin. After incubation for 2 h, the cells were transduced
with adenovirus constructs containing protein kinase A (PKA)- or
Epac2-based cAMP biosensors, as described previously [4,22,24].
Imaging experiments were conducted 48–72 h after infection. Except
where noted, all other experiments were carried out using myocytes
resuspended in extracellular solution containing (in mM) NaCl 137,
KCl 5.4, MgCl2 0.5, CaCl2 1.0, NaH2PO4 0.33, HEPES 5, glucose 5.5, pH
7.4, and used on the day of isolation. All experiments were conducted
at room temperature.
Electrophysiology
Electrophysiology experiments were carried out using K+-free
extracellular solution in which KCl was replaced with CsCl. Whole-cell
currents were recorded using a Multiclamp 700B ampliﬁer, Digidata
1440A digitizer, and pClamp software (Axon Instruments). Micro-
electrode resistances were between 1 and 2 MΩ when ﬁlled with
intracellular solution containing (in mM) CsCl 130, TEA-Cl 20, EGTA 5,
MgATP 5, TrisGTP 0.06, and HEPES 5 (pH 7.2). The voltage-clamp
protocol employed a holding potential of−80 mV. A 50 ms pre-pulse
to −40 mV to inactivate Na+channels was followed by 100 ms test
pulse to 0 mV to activate the L-type Ca2+ current (ICa-L). Changes
in ICa-L magnitude were monitored by repeating this protocol once
every 5 s.
FRET imaging
Experiments were carried out using intact myocytes expressing
PKA- or Epac2-based biosensors, as described previously [4,22,24].Changes in cAMP activity were deﬁned as relative changes in the ratio
of the background and bleed-through corrected CFP and YFP (FRET)
ﬂuorescence intensity measured over the area of the entire cell.
Measurement of cell length and [Ca2+]
Myocyte shortening and [Ca2+]i transients were measured
simultaneously in myocytes loaded with fura-2AM, as described
previously [25]. Cells were ﬁeld stimulated at 0.5 Hz.
Methyl-β-cyclodextrin (MβCD) treatment
Membrane cholesterol was depleted, as previously described [23],
by suspending cells in extracellular solution containing 1 mM MβCD
for 1 h at 37 °C. For FRET imaging experiments, transduced cells were
incubated in the MEM-based culture medium containing 1 mMMβCD
for 1 h at 37 °C.
Filipin, a polyene antibiotic that forms complexes with cholesterol
that can be visualized by ﬂuorescence microscopy, was used to verify
that MβCD treatment effectively depletedmembrane cholesterol [26].
Control or MβCD-treated cells were ﬁxed in 3.7% formaldehyde in
phosphate-buffered saline (PBS) for 10–15 min. Fixed cells were spun
onto microscope slides using a Shandon Cytospin. After rinsing, cells
were stained with PBS containing 0.05 mg/ml ﬁlipin (Sigma-Aldrich)
and 10% fetal bovine serum (Hyclone). Fluorescence images were
obtained using a D350/50x excitation ﬁlter, E420LP dichroic mirror,
and a 400 DCLP emission ﬁlter.
Membrane fractionation experiments
Membranes prepared from isolated myocytes were subjected to
ultracentrifugation using a discontinuous sucrose density gradient
[27]. Western blotting was then used to identify β1AR, as well as EP2,
and EP4 receptor proteins separated by SDS-PAGE. Caveolar and extra-
caveolar membrane fractions were identiﬁed by blotting for caveolin
3 (Cav-3) the muscle speciﬁc caveolin, and β-adaptin, respectively.
Materials
Prostaglandin E1 (PGE1, Cayman Chemicals) and ICI 118,551
(Tocris Bioscience) were prepared as stock solutions in DMSO. CGP
20712A (Tocris Bioscience) and isoproterenol bitartrate (Sigma-
Aldrich) were prepared as stock solutions in water. Isoproterenol
and 3-isobutyl-1-methylxanthine (Sigma-Aldrich) containing solu-
tions were prepared fresh daily. Fura-2AM was purchased from
Molecular Probes. β1AR, EP2R, and EP4R antibodies were obtained
from Santa Cruz Biotechnology. β-Adaptin and Cav-3 antibodies were
from BD Transduction Laboratories.
Statistics
All results are expressed as themean±SEM of the results obtained
from n number of cells. Statistical signiﬁcance between two groups
was deﬁned by Student's t-test, p values ofb0.05. For comparison of
more than 2 groups, 1-way ANOVA was used, with Holm-Sidak post
hoc analysis.
Results
It has previously been shown that the βAR agonist isoproterenol
(Iso) and the EPR agonist prostaglandin E1 (PGE1) both stimulate
cAMP production in adult cardiac myocytes, but only Iso enhances the
L-type Ca2+ current (ICa-L) [4,5]. The differences in the effects of these
agonists on the ICa-L are illustrated in Fig. 1A and B. To determine
whether or not this disparity in functional responses correlates with a
difference in where the corresponding receptors are found in the
Fig. 1. Effect of the β-adrenergic receptor (βAR) agonist isoproterenol (Iso) and the E-type prostaglandin receptor (EPR) agonist PGE1 on the L-type Ca2+ current (ICa-L) in rat
ventricular myocytes. A, Time course of changes in ICa-L amplitude and corresponding sample current traces (inset) under control conditions (a) and following exposure to 30 nM Iso
(b). B, Time course of changes in ICa-L amplitude and corresponding sample current traces (inset) under control conditions (a), and following exposure to 10 μM PGE1 (b) and 30 nM
Iso (c). C, Average increase in ICa-L amplitude recorded in the presence of 10 μM PGE1 or 30 nM Iso (**pb0.05). D, Western blot of ventricular myocyte membrane fractions obtained
by sucrose density centrifugation. Caveolin-3 (Cav-3) was used as a marker of caveolae-containing buoyant membranes (fraction 5); β-adaptin was used as a marker of heavy non-
caveolar membranes (fractions 9–12).
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ments. Membranes prepared from isolated myocytes were subjected
to ultracentrifugation using a discontinuous sucrose density gradient.
Immunoblotting was then used to identify β1ARs, as well as EP2, and
EP4 receptors, the EPR subtypes associated with cAMP production
[28]. The results (Fig. 1D) indicate that the β1AR can be detected in all
fractions, including the caveolar fraction (5), which is identiﬁed by its
enrichment in the caveolar protein, caveolin-3. The results also
demonstrate that EP2 and EP4 receptors are expressed in these cells.
However, unlike the β1AR, the EP receptors are excluded from
caveolar membrane fractions.
In neonatal ventricular myocytes, cholesterol depletion has been
shown to have no effect on the ICa-L response to maximal β1AR
stimulation [29]. However, there are signiﬁcant differences between
neonatal and adult ventricular myocytes that can affect compartmen-
tation of cAMP signaling [19,30]. Therefore, we examined the effect of
cholesterol depletion on the ICa-L response to β1AR stimulation in
adult myocytes. To do this, wemeasured the effects produced by Iso at
sub-maximally (1 nM) and maximally (30 nM) stimulating concen-
trations. In control cells, 1 nM Iso increased the ICa-L by 15±5.0%
(n=13) over baseline. Subsequent exposure to 30 nM Iso increased
the current by 69±6.6% (n=13) (Fig. 2A and E).
This experiment was then repeated in cells pretreated with 1 mM
methyl-β-cyclodextrin (MβCD) for 1 h at 37 °C. This approach has
been used previously to deplete membrane cholesterol and disrupt
lipid rafts and caveolae in cardiac myocytes [23,29,31]. Consistent
with this, MβCD treatment signiﬁcantly reduced the membrane
cholesterol content as detected by staining with the ﬂuorescent
polyene antibiotic ﬁlipin (Fig. 2F). Furthermore, when MβCD-treated
cells were exposed to 1 nM Iso, the ICa-L increased to 49±8.3% (n=5)
over baseline. This represents a 3.2-fold increase in the magnitude of
the response to this sub-maximally stimulating concentration of Isocompared with that seen in control cells. Exposure to 30 nM Iso
increased the current by 79.2±7.2% (n=6) over baseline (Fig. 2B and
E), which was not signiﬁcantly different from the response observed
in control cells.
Rat ventricular myocytes express both β1 and β2ARs, and both
receptor subtypes have been reported to stimulate L-type Ca2+
channel activity in these cells [32]. To verify that the consequence of
MβCD treatment was due to an effect on β1AR responses, we repeated
the above experiments in the presence of 100 nM CGP20712A (CGP),
a selective β1AR antagonist [33]. In cells pretreated with 100 nM CGP,
subsequent exposure to 1 nM Iso produced no response (n=4)
(Fig. 2E). CGP also blocked the effect of 1 nM Iso inMβCD-treated cells
(n=5) (Fig. 2C and E). As a positive control, subsequent exposure to
the phosphodiesterase inhibitor IBMX was used to elicit a maximal
response. These results support the conclusion that cholesterol
depletion enhances ICa-L sensitivity to β1AR stimulation.
It has been reported that L-type Ca2+ channels are found in the
caveolarmembrane fraction of cardiacmyocytes [29,34]. To determine
whether or not the effect of cholesterol depletionwas speciﬁc for β1AR
regulation of the ICa-L, we also examined the effect of MβCD treatment
on the intracellular Ca2+ ([Ca2+]i) transient and myocyte contraction
(Fig. 3). In these experiments, myocytes were exposed to 1 nM Iso in
the presence of 100 nM ICI 118,551 (ICI), a β2AR antagonist, to
selectively activate β1ARs [33]. As expected, this protocol resulted in a
signiﬁcant increase in the magnitude of the [Ca2+]i transient and
myocyte shortening in untreated cells. Following exposure to Iso, the
relative degree of cell shortening increased by 63±13% and the
magnitude of the [Ca2+]i transient increased by 18±4.1% (n=17).
These effects were also accompanied by a signiﬁcant increase in the
rate with which both parameters returned to baseline.
The half-time (t0.5) for relaxation of cell shortening decreased by
17±3.8% and the t0.5 for decay of the [Ca2+]i transient decreased by
Fig. 2. Effect of cholesterol depletion on L-type Ca2+ current (ICa-L) responses to isoproterenol (Iso) and PGE1. Time courses of change in ICa-L amplitude and corresponding sample
current traces (inset). A, Untreated cell under control conditions (a), and following exposure to 1 nM (b) and 30 nM (c) Iso. B, MβCD-treated cell under control conditions (a), and
following exposure to 1 nM (b) and 30 nM (c) Iso. C, MβCD-treated cell in the presence of the selective β1-adrenergic receptor antagonist CGP20712A (CGP, 100 nM) (a), and
following exposure to CGP plus 1 nM Iso (b) and 1 μM Iso plus the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX, 100 μM) (c). D, MβCD-treated cell under control
conditions (a), and following exposure to 10 μM PGE1 (b) and 30 nM Iso (c). E, Average change in ICa-L amplitude in untreated and MβCD-treated myocytes (**pb0.05, ns=not
signiﬁcant, see text for n numbers). F, Effect of MβCD treatment on membrane cholesterol content detected by ﬁlipin staining.
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myocytes, the response to 1 nM Iso was signiﬁcantly enhanced. The
relative degree of cell shortening increased by 188±19.5% and the
magnitude of the [Ca2+]i transient increased by 35±4.3% (n=22).
There were also signiﬁcant changes in the rate that both parameters
returned to baseline. The t0.5 for relaxation of cell shortening
decreased by 35±4.3% and the t0.5 for decay of the [Ca2+]i transient
decreased by 30±1.7%.
Next we examined the effect of MβCD treatment on responses
to PGE1. If the effect of cholesterol depletion is a non-speciﬁc
effect altering all receptor-mediated cAMP-dependent responses,
then it is conceivable that this treatment might also alter the
response to PGE1, revealing functional effects not observed in
control cells. Such an effect might be expected if compartmenta-
tion of PGE1 responses is due to exclusion of EP receptors from
lipid raft domains, given that membrane fractionation studies
suggest that cholesterol depletion causes a redistribution of
membrane proteins involved in cAMP signaling [18,35,36]. How-
ever, neither of these possibilities appeared to be true. Exposure to
PGE1 did not alter the ICa-L in either untreated (see Fig. 1) orMβCD-treated cells (see Fig. 2D and E). Consistent with this, PGE1
did not signiﬁcantly affect the [Ca2+]i transient or myocyte
shortening in either untreated or MβCD-treated cells (see Fig. 3).
These results suggest that the effect of MβCD treatment and
cholesterol depletion was not a non-speciﬁc effect, since it
selectively altered responses produced by β1AR stimulation.
Evidence presented here and elsewhere indicates that in cardiac
myocytes, β1ARs can be found in all membrane fractions, not just
those associated with caveolin [19,29,35]. This raises the question of
whether or not the change in sensitivity to β1AR signaling caused by
cholesterol depletion is due to an effect on those receptors speciﬁcally
associated with caveolar lipid raft domains. To address this question,
we examined the effect of cholesterol depletion on β-adrenergic
stimulation of cAMP production in intact myocytes using different
FRET-based biosensors.
In the ﬁrst set of experiments, we used a PKA-based biosensor
(Fig. 4) [4,24]. This particular probe contains the type II regulatory
(RII) subunit of PKA [37]. Because of this, it is targeted to speciﬁc
subcellular locations through its interactions with A kinase anchoring
proteins (AKAPs) [4,37]. This includes caveolar fractions of the plasma
***
***
**
**
-40
-20
0
0
20
40
-40
-20
0
Cell Shortening
0
100
200
nsns
ns
ns
Iso PGE1 Iso PGE1
A B
-MβCD +MβCD -MβCD +MβCD
-MβCD
+MβCD
1 nM
Iso
10 μM
PGE1
DC
Δ 
ce
ll 
sh
or
te
ni
ng
 (%
)
Δ 
t 0.
5 
re
la
xa
tio
n 
(%
)
Δ 
[C
a2+
] i t
ra
ns
ie
nt
 (%
)
[Ca2+]i transient
Δ 
t 0.
5 
de
ca
y 
(%
)
Fig. 3. Effect of cholesterol depletion on intracellular Ca2+ ([Ca2+]i) transient and cell shortening responses to isoproterenol (Iso) and PGE1. A, Cell shortening elicited by electric ﬁeld
stimulation before (black traces) and after (gray traces) exposure to 1 nM Iso (upper panels) and 10 μM PGE1 (lower panels) in untreated cells (left hand panels) andMβCD-treated
cells (right hand panels). Scale bars: 200 ms, 4% resting of cell length. B, [Ca2+]i transients elicited by electric ﬁeld stimulation before (black traces) and after (gray traces) exposure to
1 nM Iso (upper panels) and 10 μM PGE1 (lower panels) in untreated cells (left hand panels) and MβCD-treated cells (right hand panels). Scale bars: 200 ms, 0.4 relative units.
C, Average cell shortening responses expressed as the change relative to resting cell length in untreated and MβCD-treated cells (upper panel); average change in time to half (t0.5)
relaxation of cell shortening in control and MβCD-treated cells (lower panel). D, Average [Ca2+]i transient responses expressed as the change in fura-2 ﬂuorescence ratio relative to
baseline in untreated andMβCD-treated cells (upper panel); average change in t0.5 decay of the [Ca2+]i transient in control andMβCD-treated cells (lower panel). Responses to 1 nM
Iso were recorded in the presence of 100 nM ICI 118,551, a selective β2 receptor antagonist (**pb0.01, ***pb0.001, ns=not signiﬁcant; see text for n numbers).
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in cAMP that occur in microdomains that include caveolar lipid raft
domains [38]. Consistent with this idea, we have previously
demonstrated that it detects cAMP responses that are distinctly
different from those occurring in the total cytosolic cAMP compart-
ment [4,22].
In control myocytes expressing the PKA-based biosensor, exposure
to 0.3 nM Iso produced a 2.7±0.7% change in the FRET response
(n=7). Subsequent exposure to 30 nM Iso increased the FRET
response to 11.2±2.4% of control (n=7) (Fig. 4A and C). When
these experiments were repeated in MβCD-treated myocytes, 0.3 nM
Iso produced a 6.3±1.4% change in the FRET response (n=6), which
increased to 10.8±2.0% (n=6) following subsequent exposure to
30 nM Iso (Fig. 4B and C). These results indicate that cholesterol
depletion caused a signiﬁcant increase in the sensitivity of the
response to sub-maximally, but not maximally stimulating concen-
trations of Iso. Furthermore, these effects were blocked in the
presence of CGP, but not ICI (Fig. 4D), conﬁrming that the increase
in sensitivity of the PKA-based biosensor's response to Iso caused by
cholesterol depletion was due to an effect on β1AR signaling.It is unlikely that the effects of cholesterol depletion are due to
disruption of AKAP binding causing the redistribution of type II PKA
and the PKA-based biosensor. This is because disrupting AKAP
targeting of type II PKA has been shown to diminish β-adrenergic
regulation of L-type Ca2+ channels [39], which is opposite to the
enhanced response we observed following cholesterol depletion.
Furthermore, the PKA-based biosensor is expressed in a striated
pattern along T tubules in adult ventricular myocytes [24], and we
previously demonstrated that blocking PKA anchoring to AKAPs
disrupts this pattern [4]. However, when we examined the expression
pattern in a similar manner following MβCD treatment, we found no
change (see Supplementary Fig. S1).
Because these experiments involved the use of cells maintained in
culture for up to 72 h, we also examined the effect that this had on
their cholesterol content and found that there was a time dependent
decrease. After 72 h, the cholesterol content, as determined by ﬁlipin
staining, was reduced by N50% (see Supplementary Fig. S2).
Nevertheless, the response observed in MβCD-treated cells was
consistent with an effect due to depletion of the remaining
cholesterol. This is supported by the fact that treatment with α-
Fig. 4. Effect of cholesterol depletion on intracellular cAMP response to β-adrenergic receptor stimulation detected by the type II PKA biosensor. Time course of changes in FRET
response (ΔR/R0) and corresponding pseudocolor images recorded under control conditions (a), and following exposure to 0.3 nM (b) and 30 nM Iso (c) in an untreated cell (A) and
a MβCD-treated cell (B). Scale bar, 10 μm. C, Average changes in FRET responses in untreated and MβCD-treated cells. D, Average changes in FRET response to 0.3 nM Iso in MβCD-
treated cells recorded in the presence of the β1 receptor antagonist CGP20712A (CGP, 100 nM) or the β2 receptor antagonist ICI 118,551 (ICI, 100 nM) (**pb0.05, ns=not
signiﬁcant).
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had no effect on PKA probe response to β1AR stimulation (see
Supplementary Fig. S3).
In the next set of experiments, we examined the effect of
cholesterol depletion on cAMP responses detected using Epac2-
camps (Fig. 5), a biosensor created using one of the cAMP binding
domains from the type 2 exchange protein activated by cAMP [41].
Because it lacks any of the anchoring sequences found in the full-
length protein, it is expressed uniformly throughout the cytoplasm of
the cell. As a result, it is able to respond to changes in total cellular
cAMP [22]. We have previously demonstrated that the responses
detected by this Epac2-based biosensor are distinctly different from
those detected by the PKA-based biosensor [4]. In control myocytes
expressing the Epac2 probe, exposure to 1 nM Iso produced a
4.1±0.8% change in the FRET response. This increased to 10.2±
1.4 % upon exposure to 30 nM Iso (n=6). When this experiment was
repeated inMβCD-treated cells, there was no signiﬁcant change in the
response to either concentration of Iso. The FRET responses to 1 nM
and 30 nM Iso were 4.8±0.7% and 9.7±0.9%, respectively (n=5).
These results suggest that the Epac2 probe is more sensitive to cAMP
produced by β1ARs found outside of lipid raft domains.
In a ﬁnal set of experiments, we examined the effect of PGE1 on
cAMP responses detected by both FRET-based biosensors. We have
previously demonstrated that PGE1 is able to elicit a transient increase
in cAMP that is detected by the Epac2 probe, but not the PKA probe in
adult guinea pig ventricular myocytes [4]. Consistent with this, we
found that exposure to 10 μM PGE1 produced a similar transient
increase in cAMP that was detected by the Epac2 probe in adult rat
ventricular myocytes (Fig. 6A). This conﬁrms that PGE1 is indeed
capable of stimulating cAMP production in these cells. Exposure to
PGE1 also produced a transient response that was detected by the
Epac2 probe in MβCD-treated cells (Fig. 6B). However, the magnitude
of the response was not signiﬁcantly different from what wasobserved in control cells (Fig. 6C). Surprisingly, when these experi-
ments were repeated in myocytes expressing the PKA probe, PGE1
treatment still elicited a transient change in FRET response (Fig. 6D).
However, the magnitude of the transient response was not signiﬁ-
cantly different between control and MβCD-treated myocytes
(Fig. 6E and F).
The ability of PGE1 to stimulate cAMP production, even though it
had no effect on functional responses, supports the idea that the cAMP
produced by PGE1 is compartmentalized. However, because the cAMP
responses were measured in cells maintained in culture, it is possible
that changes in their composition or structure could have created this
apparent discrepancy. To address this possibility, we looked at the
effect of 10 μM PGE1 on the ICa-L current in cells kept in primary
culture for 72 h. Just as in freshly isolated cells, PGE1 had no effect on
the ICa-L, despite the fact that subsequent exposure to 30 nM Iso
produced a normal response (see Supplementary Fig. S4). These
results suggest that compartmentation of cAMP signaling is not
altered by any changes that may have occurred with time in culture.
Discussion
The observation that two agonists can differ in their capacity to
elicit PKA-dependent responses, despite the fact that they both
stimulate cAMP production, cannot be easily reconciled if it is
assumed that the receptors involved are distributed uniformly
throughout the plasmamembrane. In the present study, we examined
the role that differences in the distribution of β1ARs and EPRs in
cholesterol-dependent lipid rafts may play in contributing to the
disparities in functional responses they produce. Previous studies
have used biochemical methods to demonstrate that caveolar lipid
rafts are associated with the segregation of various G-protein-coupled
receptors [14], but most studies involving cardiac myocytes have
relied on the use of neonatal cells [21,29,35,42], and none have looked
Fig. 5. Effect of cholesterol depletion on intracellular cAMP response to β-adrenergic
receptor stimulation detected by the Epac2 biosensor. Time course of changes in FRET
response (ΔR/R0) and corresponding pseudocolor images under control conditions (a),
and following exposure to 1 nM (b) and 30 nM Iso (c) in an untreated cell (A) and a
MβCD-treated cell (B). Scale bar, 10 μm. C, Average change in FRET responses in
untreated cells and MβCD-treated cells (ns=not signiﬁcant).
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functional responses in adult myocytes. Because neonatal myocytes
exhibit signiﬁcant differences in structure and cell signaling responses
[43,44], we chose to conduct our studies using adult ventricular
myocytes. To gain further insight into the role of lipid rafts in
generating compartmentalized responses by both β1ARs and EPRs, we
also used live cell imaging of FRET-based biosensors to measure cAMP
responses in different microdomains of intact myocytes.
The results of the present work indicate that even though both
β1ARs and EPRs were able to stimulate cAMP production, as detected
by FRET-based biosensors, only β1ARs were able to enhance the ICa-L,
[Ca2+]i transient and myocyte shortening. Furthermore, we observed
that β1ARs are found in caveolar as well as extra-caveolar fractions of
the plasma membrane, while EPRs were only found in extra-caveolar
fractions. When myocytes were then treated with MβCD to deplete
cholesterol and disrupt lipid rafts, β1AR sensitivity of functional
responses was enhanced. Consistent with this observation, MβCD
treatment also enhanced β1AR sensitivity of the PKA probe response.
However, MβCD treatment had no effect on the Epac2 probe response
to β1AR stimulation, and it had no effect on any response to PGE1.
These results support the idea that segregation of speciﬁc G-protein-coupled receptors within the membrane is an underlying mechanism
of separation of function associated with different cAMP signaling
pools. They also suggest that β1-adrenergic regulation of the
functional responses described in this study is speciﬁc to receptors
found in caveolar membrane domains.
The fact thatMβCD treatment did not alter the PKA probe response
to PGE1 suggests that the effect of cholesterol depletion was not due
to a direct effect on endogenous PKA or the PKA probe. Themore likely
explanation for our results is that cholesterol depletion increased
myocyte sensitivity to β1AR stimulation of cAMP production. This
conclusion is consistent with biochemical studies reporting that
cholesterol depletion increases βAR stimulation of cAMP production
in various cell types [15,35,36]. Rybin et al. [35] suggested that this can
be explained by a direct interaction between adenylyl cyclase and the
inhibitory scaffolding domain of caveolin-3. They concluded that
cholesterol depletion disrupts this interaction, relieving its inhibitory
effect on cAMP production. Removal of such an inhibitory effect could
then explain the shift in sensitivity to β1AR stimulation that we
observed.
In another study using neonatal rat ventricular myocytes, Ostrom
et al. [18] reported that cholesterol depletion actually inhibits βAR
stimulation of cAMP production. The reason for the apparent
discrepancy is unclear. However, they also found that EPR stimulation
of cAMP production was unaltered. Their conclusion was that
cholesterol depletion only affects responses associated with receptors
found in caveolar lipid rafts, which is consistent with our results in
intact adult myocytes. More recently, Balijepalli et al. [29] reported
that cholesterol depletion had no affect on β1AR regulation of the ICa-L
in neonatal mouse ventricular myocytes. Yet, their study only
compared responses to maximal receptor activation. Consistent
with that, our present work found that cholesterol depletion did not
alter responses to maximal β1AR stimulation, it only increased
responses to sub-maximal β1AR stimulation, indicating that choles-
terol depletion was shifting the sensitivity to receptor activation. Our
previouswork has shown evidence of a trend for cholesterol depletion
to enhance β1AR responses produced by 5 nM Iso, although the effects
were not statistically signiﬁcant [23]. The greater effect observed in
the present study may be explained by our use 1 nM Iso, a
concentration much further from that which produces maximal
responses.
Our ﬁnding that cholesterol depletion increased β1AR sensitivity of
responses detected by the PKA-based biosensor, but not the Epac2-
based biosensor, suggests that the regulation of electrical and
mechanical activity involves the production of cAMP in a micro-
domain associated with type II PKA by receptors found in cholesterol-
dependent lipid rafts. It also suggests that β1AR stimulation of cAMP
throughout the rest of the cell may be mediated by receptors that are
found primarily outside of lipid rafts. These results, together with the
fact that PGE1 still had no effect on functional responses following
cholesterol depletion, demonstrate that while receptors in lipid raft
and non-lipid raft domains can produce compartmentalized
responses, compartmentalized behavior still exists even after lipid
rafts have been disrupted. This implies that cholesterol depletion may
not be causing signiﬁcant redistribution of these receptors and that
something else must contribute to their association with different
cAMP signaling domains. Although this appears to be different from
the effect that cholesterol depletion has on β2ARs [17], it is consistent
with reports that cholesterol depletion has no effect or actually
decreases the mobility of many plasma membrane proteins, possibly
due to the existence and/or enhancement of other barriers, such as
actin cytoskeleton or solid phase phospholipids [45].
Another important observation made in the present study is that
cholesterol depletion not only enhanced the magnitude of the [Ca2+]i
transient and myocyte shortening responses to β1AR stimulation, it
also affected the rate of transient decay and the rate of relaxation.
While an increase in the magnitude of the ICa-L could conceivably
Time (min)
0
1
2
3
Time (min)
0
1
2
3
PG
E1
 R
es
po
ns
e
0
1
2
3
4
10 μM PGE1 10 μM PGE1
10 μM PGE1 10 μM PGE1
A
B
C
-MβCD
+MβCD
-MβCD +MβCD -MβCD +MβCD
-MβCD
+MβCD
n=5 n=6
Time (min)
0
2
4
Time (min)
3 4 5
3 4 5
42
2
30 1
0 1
20 1
0 1 2 3 4
0
2
4
PG
E1
 R
es
po
ns
e
0
1
2
3
4
n=9 n=6
ns
ns
D
E
F
PKA probeEpac2 probe
ΔR
/R
0 
(%
)
ΔR
/R
0 
(%
)
ΔR
/R
0 
(%
)
ΔR
/R
0 
(%
)
Fig. 6. Effect of cholesterol depletion on intracellular cAMP response to PGE1. Time course of FRET response detected by Epac2-based biosensor (A, B) or type II PKA-based biosensor
(D, E) following exposure to 10 μMPGE1 in untreated cells (A, D) andMβCD-treated cells (B, E). Average changes in FRET response to 10 μMPGE1 detected by Epac2-based biosensor
(C) and PKA-based biosensor (F) in untreated and MβCD-treated cells (ns=not signiﬁcant).
507S.R. Agarwal et al. / Journal of Molecular and Cellular Cardiology 50 (2011) 500–509explain the change in the magnitude of those other responses, it is
unlikely to explain the change in their kinetics. The faster decay of the
[Ca2+]i transient most likely reﬂects an increase in the rate of Ca2+
uptake by the sarcoplasmic reticulum Ca2+ ATPase due to PKA-
dependent phosphorylation of phospholamban [2]. Such an effect is
also likely to contribute to the faster relaxation of myocyte shortening,
although PKA- dependent phosphorylation of troponin I could also
play a role. These observations indicate that β1AR regulation of
myocyte contraction correlatesmore closely with the local production
of cAMP by a subpopulation of receptors associated with lipid rafts
and that it is not just L-type Ca2+ channels that are under the local
control of cAMP production by β1ARs.
The present study also demonstrates some interesting new aspects
of the compartmentalized response associated with EP receptor
activation. In the original study using isolated adult cardiac myocytes,
Buxton and Brunton [3] employed a biochemical approach and found
that PGE1 stimulated cAMP production in the soluble fraction, but not
the particulate fraction, of homogenized myocytes. Following the
development of biosensors capable of measuring cAMP activity in
intact cells, Rochais et al. [5] used an exogenously expressed, cyclic
nucleotide gated (CNG) ion channel, but found that it was unable to
detect a cAMP response produced by PGE1 in adult rat ventricular
myocytes. However, in our previous study using adult guinea pig
ventricular myocytes, we found that PGE1 elicited a transient increase
in cAMP detected by the Epac2-based probe, yet it had no effect on the
cAMP response detected by the type II PKA-based probe anchored byAKAPs [4]. Similar results were reported in neonatal rat ventricular
myocytes, where PGE1 stimulation was found to produce a more
signiﬁcant cAMP response outside of the type II PKA signaling domain
[46]. This is in contrast to the present study in adult rat ventricular
myocytes, where we found that PGE1 produced a transient cAMP
response detected by both the Epac2- and type II PKA-based probes.
This apparent discrepancy may reﬂect developmental and/or species-
dependent differences in the distribution of type II PKA. Despite the
fact that PGE1 produced a response detected by the PKA probe, it had
no effect on any of the functional properties studied. This suggests
that in rat ventricular myocytes, the type II PKA signaling domain
includes one or more subcellular compartments distinctly separate
from those involved in regulating electrical ormechanical activity. The
observation that EP2 and EP4 receptors are found in extra-caveolar
fractions of the plasma membrane suggests that PGE1 is producing
cAMP in a subset of the PKA signaling domain not associated with
caveolar lipid rafts. Consistent with this idea, evidence for type II PKA
has been found in both caveolar and extra-caveolar membrane
fractions of cardiac ventricular myocytes [29,35]. The question
remains as to whether or not all or only some of the extra-caveolar
PKA sees the cAMP produced by PGE1.
Potential limitations
Experiments involving the use of FRET-based biosensors were
carried out in myocytes kept in culture for 48–72 h, while most
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possible that changes in the composition or structure of the cultured
cells could have altered some of the cAMP responses we measured.
For example, we observed that cholesterol content decreased with
time. Still, this did not alter the inability of PGE1 to regulate Ca2+
channel function, which conﬁrmed that compartmentation of cAMP
signaling occurs in cultured cells. It has also been reported that T
tubule density decreases with time in culture [47]. In adult ventricular
myocytes, L-type Ca2+ channels involved in the regulation of
excitation contraction coupling are located in T tubules, and a loss
of T tubules has been shown to attenuate the ICa-L response to βAR
regulation [48]. However, we found that β1AR of the ICa-L current was
unaffected in cultured cells. The fact that cholesterol depletion altered
the sensitivity of β1AR stimulation of cAMP detected by the PKA probe
is also unlikely to have been due to the fact that those experiments
were conducted in cultured cells since cholesterol depletion had a
similar effect on cAMP-dependent functional responses in freshly
isolated cells. Even so, we cannot rule out a potential contribution of
changes occurring in culture to at least some of our observations.
Conclusions
The present results support the idea that cAMP responses
produced by receptors found in lipid rafts domains are sensitive to
cholesterol depletion, while responses produced by receptors found
outside of lipid raft domains are not. Based on this conclusion, the
effects of cholesterol depletion suggest that β1 adrenergic regulation
of electrical andmechanical responses in adult ventricularmyocytes is
mediated by those receptors associated speciﬁcally with lipid raft
domains. Finally, even though cholesterol-dependent lipid rafts
appear to be associated with compartmentalized cAMP responses,
they alone are not sufﬁcient to explain what is responsible for the
difference between signaling domains associated with β1 adrenergic
and EP receptors.
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